Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TransMedics Group, Inc. | VP, Global Regulatory Affairs | Common Stock | 23.3K | $2.1M | $90.09 | Dec 15, 2023 | Direct |
TransMedics Group, Inc. | VP, Global Regulatory Affairs | Stock Option (Right to Buy) | 7.81K | Dec 13, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TMDX | TransMedics Group, Inc. | Dec 13, 2023 | 10 | -$56.6K | 4 | Dec 15, 2023 | VP, Global Regulatory Affairs |
TMDX | TransMedics Group, Inc. | Aug 31, 2023 | 5 | -$32.3K | 4 | Sep 5, 2023 | VP, Global Regulatory Affairs |
TMDX | TransMedics Group, Inc. | Feb 20, 2023 | 2 | $0 | 4 | Feb 22, 2023 | VP, Global Regulatory Affairs |
TMDX | TransMedics Group, Inc. | Dec 13, 2022 | 4 | -$42.2K | 4 | Dec 15, 2022 | VP, Global Regulatory Affairs |
TMDX | TransMedics Group, Inc. | Sep 2, 2022 | 8 | -$33.3K | 4 | Dec 13, 2022 | VP, Global Regulatory Affairs |
TMDX | TransMedics Group, Inc. | Feb 22, 2022 | 1 | $0 | 4 | Feb 24, 2022 | VP of Global Regl. Affairs |
TMDX | TransMedics Group, Inc. | Dec 23, 2021 | 2 | $2.85K | 4 | Dec 28, 2021 | VP of US Regulatory & FDA Rel. |
TMDX | TransMedics Group, Inc. | Sep 15, 2021 | 3 | -$30.7K | 4 | Sep 17, 2021 | VP of US Regulatory & FDA Rel. |
TMDX | TransMedics Group, Inc. | Jul 30, 2021 | 2 | $7.1K | 4 | Aug 3, 2021 | VP of US Regulatory & FDA Rel. |